Durability of hbeag seroconversion in chronic hepatitis B patients after lamivudine A-interferon or lamivudine A- interferon combination therapy

Authors :: S.W. Schalm
R.A. de Man
H. Loehr
B C Song
Jenny Heathcote
Liliana Chemello
D J Suh
B.E. Hansen
H.L.A. Janssen
H. Fontaine
A.B. van Nunen
Source :: Journal of Hepatology. 34:155
Publication Year :: 2001
Publisher :: Elsevier BV, 2001.

Subjects :: Hepatology
Combination therapy
Chronic hepatitis
Hbeag seroconversion
business.industry
Interferon
Medicine
Lamivudine
business
Virology
medicine.drug

Full Text Access

Tools